Showing results (181-190 of 241) with videos related to
Sort By:
Pageof 25
Breast Cancer Research and Treatment|October 24, 2018
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence scorePiiha-Lotta Jerevall, Jane Brock, Juan Palazzo, et al.Breast Cancer Research : BCR|March 13, 2012
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expressionMohan Liu, Liewei Wang, Tim Bongartz, et al.Annals of Surgery|June 9, 2017
Enhanced Recovery After Surgery (ERAS) Eliminates Racial Disparities in Postoperative Length of Stay After Colorectal SurgeryTyler S Wahl, Lauren E Goss, Melanie S Morris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2018
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 YearsJulie Lemieux, Michael D Brundage, Wendy R Parulekar, et al.Biological Psychiatry|July 26, 2020
Transcriptional Profiling of Primate Central Nucleus of the Amygdala Neurons to Understand the Molecular Underpinnings of Early-Life Anxious TemperamentRothem Kovner, Tade Souaiaia, Andrew S Fox, et al.Clinical Pharmacology and Therapeutics|May 28, 2021
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast CancerJunmei Cairns, Krishna R Kalari, James N Ingle, et al.Cancer|December 12, 2007
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge ConferenceSteven E Come, Aman U Buzdar, James N Ingle, et al.Breast Cancer Research and Treatment|January 12, 2011
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal womenT Cigler, H Richardson, M J Yaffe, et al.Breast Cancer Research : BCR|August 27, 2013
Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC CohortJudith-Anne W Chapman, Torsten O Nielsen, Matthew J Ellis, et al.Breast Cancer Research : BCR|January 6, 2016
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 studyDennis C Sgroi, Judy-Anne W Chapman, T Badovinac-Crnjevic, et al.Pageof 25